DOXIL
doxorubicin hydrochloride
- Strength
- 2 mg/mL
- Form
- Injection, Suspension, Liposomal
- Class
- Anthracycline Topoisomerase Inhibitor
Baxter Healthcare Corporation
Not stocked by us — reference only
Listed by Zydus Pharmaceuticals USA Inc.
| Dosage form | Injectable, Liposomal |
|---|---|
| Route | Intravenous |
| Drug class | Anthracycline Topoisomerase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 70710-1531 |
| FDA application | ANDA212299 |
| RxNorm concept | 1790115 |
| Package sizes listed | 1 |
| Marketed since | September 2020 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
doxorubicin hydrochloride
Baxter Healthcare Corporation
Not stocked by us — reference only
doxorubicin hydrochloride
Baxter Healthcare Company
Not stocked by us — reference only
doxorubicin hydrochloride
Baxter Healthcare Company
Not stocked by us — reference only
doxorubicin hydrochloride
Baxter Healthcare Corporation
Not stocked by us — reference only
Pfizer Laboratories Div Pfizer Inc
Not stocked by us — reference only
Sun Pharmaceutical Industries, Inc.
Not stocked by us — reference only
BluePoint Laboratories
Not stocked by us — reference only
Gland Pharma Limited
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.